STONE CHRISTOPHER LEWIS (VP, Gen. Counsel & Secretary) sold 33.0% of their position (200K shares) of PDL BIOPHARMA, INC. on the open market
Open‑market sale worth $512.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/17/2020ACC: 0000882104-20-000211
Officer· VP, Gen. Counsel & Secretary
Since Sep 2018
-200K
Net shares
Net seller
$512.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
200K disposed
Non-Derivative Transactions1
Common stock
Direct
Shares
−200K
Price / share
$2.56
Trade value
$512K
% of position
33.0%
12/16/2020
605.56K→405.56K
Total
Net shares
−200K
Net value
-$512K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 12/16/2020 | S · Sale | −200K | $2.56 | $512K | 33.0% | 605.56K | 405.56K |
| Total | −200K | -$512K | ||||||
Derivative Transactions0
No derivative transactions reported